目的:观察西沙必利联合康复新液治疗反流性食管炎疗效。方法:选取我院2012年2月至2013年8月在我院就诊的120例反流性食管炎患者,按照就诊先后顺序编号,使用抛硬币法随机分为观察组和对照组,各60例。观察组给予西沙必利联合康复新液治疗,对照组给予西沙必利联合康复新液治疗,对比分析两组治疗效果。结果:治疗后观察组烧心、反酸、胸骨灼热或上腹疼痛症状明显好转率为95.0%(57/60),对照组为76.67%(46/60),两组差异有统计学意义(χ2=8.292,P=0.004);观察组治疗后临床疗效胃镜检查结果均明显优于对照组(P<0.05);观察组治疗胃镜检查结果均明显优于对照组(P<0.05);两组患者治疗过程中未观察到明显的不良反应,均能顺利完成治疗。结论:西沙必利联合康复新液治疗反流性食管炎临床疗效明显,不良反应少,安全性高。 Objective: To observe the curative effect of cisapride combined with rehabilitation new liquid on reflux esophagitis. Methods: A total of 120 patients with reflux esophagitis who were treated in our hospital from February 2012 to August 2013 were selected according to the order of their visits and randomly divided into observation group and control group by coin-tossing method. All 60 patients . The observation group was given cisapride combined with rehabilitation of new liquid treatment, the control group was given cisapride combined rehabilitation of new liquid treatment, comparative analysis of the two groups of treatment. Results: After treatment, the rate of improvement of heartburn, acid reflux, sternal burning or upper abdominal pain was significantly improved in 95.0% (57/60) and 76.67% (46/60) in the control group, with significant difference between the two groups (χ2 = 8.292, P = 0.004). The results of gastroscopy in observation group were significantly better than those in control group (P <0.05). The results of gastroscopy in observation group were significantly better than those in control group (P <0.05) No obvious adverse reactions were observed in the course of treatment and the treatment could be successfully completed. Conclusion: Cisapride combined with Kangfuxin solution has obvious curative effect on reflux esophagitis with less side effects and high safety.